ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,359.06
      -0.60%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. KALA BIO Inc (KALA)

      7. KALA BIO Inc (KALA) News

      KALA

      KALA BIO (KALA)

      KALA BIO Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KALA
      DateTimeSourceHeadlineSymbolCompany
      03/29/20248:00AMGlobeNewswire Inc.KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      03/04/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
      02/26/20248:00AMGlobeNewswire Inc.KALA BIO to Present at TD Cowen 44th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
      02/14/20241:09PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KALAKALA BIO Inc
      02/06/20248:00AMGlobeNewswire Inc.KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:KALAKALA BIO Inc
      01/19/20244:01PMGlobeNewswire Inc.KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      01/05/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
      01/05/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
      01/05/20244:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
      01/05/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
      12/22/20238:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
      11/13/20238:10AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
      11/13/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
      11/13/20238:00AMGlobeNewswire Inc.KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      10/18/20234:04PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KALAKALA BIO Inc
      09/20/20234:01PMGlobeNewswire Inc.KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      09/05/20238:00AMGlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:KALAKALA BIO Inc
      08/04/20238:00AMGlobeNewswire Inc.KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      08/02/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
      08/02/20234:01PMGlobeNewswire Inc.KALA BIO to Participate in Upcoming Investor Conferences in AugustNASDAQ:KALAKALA BIO Inc
      08/02/20238:00AMGlobeNewswire Inc.Kala Pharmaceuticals Announces Name Change to KALA BIONASDAQ:KALAKALA BIO Inc
      07/19/20234:01PMGlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      06/23/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      06/23/20234:01PMGlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      06/22/20234:48PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KALAKALA BIO Inc
      06/15/202311:58AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KALAKALA BIO Inc
      06/02/20238:00AMGlobeNewswire Inc.Kala Pharmaceuticals to Present at the Jefferies Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
      05/31/20234:03PMEdgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:KALAKALA BIO Inc
      05/11/20235:26PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KALAKALA BIO Inc
      05/09/20238:00AMGlobeNewswire Inc.Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
       Showing the most relevant articles for your search:NASDAQ:KALA